• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

棘阿米巴角膜炎。局部用克霉唑在联合化疗中的潜在作用。

Acanthamoeba keratitis. Potential role for topical clotrimazole in combination chemotherapy.

作者信息

Driebe W T, Stern G A, Epstein R J, Visvesvara G S, Adi M, Komadina T

机构信息

Department of Ophthalmology, University of Florida College of Medicine, Gainesville 32610-0284.

出版信息

Arch Ophthalmol. 1988 Sep;106(9):1196-201. doi: 10.1001/archopht.1988.01060140356031.

DOI:10.1001/archopht.1988.01060140356031
PMID:3046582
Abstract

Clotrimazole is an antifungal agent that has been shown to have excellent in vitro activity against most strains of Acanthamoeba. We encountered four patients who developed Acanthamoeba keratitis while wearing contact lenses that had been stored in homemade saline. Their medical treatment regimens included the use of topical 1% clotrimazole. In two patients in whom conventional therapy failed, clotrimazole was successful in controlling recurrent infection following penetrating keratoplasty. Two other patients were treated with clotrimazole as well as propamidine isethionate and neomycin sulfate-polymyxin B sulfate-gramicidin from the outset, and had an excellent response to medical therapy. In those patients who found the commercially available cream uncomfortable, a 1% clotrimazole suspension formulated in artificial tears was used and found to be well tolerated.

摘要

克霉唑是一种抗真菌剂,已显示出对大多数棘阿米巴菌株具有出色的体外活性。我们遇到了四名在佩戴储存在自制盐水中的隐形眼镜时患上棘阿米巴角膜炎的患者。他们的治疗方案包括使用局部1%克霉唑。在两名传统治疗失败的患者中,克霉唑在穿透性角膜移植术后成功控制了反复感染。另外两名患者从一开始就接受了克霉唑以及羟乙磺酸丙脒和硫酸新霉素-硫酸多粘菌素B-短杆菌肽的治疗,对药物治疗反应良好。在那些觉得市售乳膏使用起来不舒服的患者中,使用了用人造泪液配制的1%克霉唑混悬液,发现耐受性良好。

相似文献

1
Acanthamoeba keratitis. Potential role for topical clotrimazole in combination chemotherapy.棘阿米巴角膜炎。局部用克霉唑在联合化疗中的潜在作用。
Arch Ophthalmol. 1988 Sep;106(9):1196-201. doi: 10.1001/archopht.1988.01060140356031.
2
Successful medical management of Acanthamoeba keratitis.棘阿米巴角膜炎的成功药物治疗
Am J Ophthalmol. 1990 Oct 15;110(4):395-403. doi: 10.1016/s0002-9394(14)77020-5.
3
Acanthamoeba keratitis associated with contact lenses: six consecutive cases of successful management.与隐形眼镜相关的棘阿米巴角膜炎:连续6例成功治疗病例
Br J Ophthalmol. 1989 Apr;73(4):271-5. doi: 10.1136/bjo.73.4.271.
4
Acanthamoeba keratitis successfully treated with prolonged propamidine isethionate and neomycin-polymyxin-gramicidin.用延长使用的依西酸丙脒腙和新霉素-多粘菌素-短杆菌肽成功治疗棘阿米巴角膜炎。
Ann Ophthalmol. 1990 Jan;22(1):20-3.
5
Medical and surgical treatment of Acanthamoeba keratitis.棘阿米巴角膜炎的药物及手术治疗
Am J Ophthalmol. 1987 May 15;103(5):615-25. doi: 10.1016/s0002-9394(14)74320-x.
6
Acanthamoeba keratitis.棘阿米巴角膜炎
Arch Ophthalmol. 1988 Sep;106(9):1181-3. doi: 10.1001/archopht.1988.01060140341027.
7
Acanthamoeba keratitis associated with soft contact lenses.与软性隐形眼镜相关的棘阿米巴角膜炎。
Am J Ophthalmol. 1985 Sep 15;100(3):396-403. doi: 10.1016/0002-9394(85)90500-8.
8
Results of a trial of combined propamidine isethionate and neomycin therapy for Acanthamoeba keratitis. Brolene Study Group.依西酸丙氧苯脒与新霉素联合治疗棘阿米巴角膜炎的试验结果。溴棕三甲铵研究组。
Ophthalmology. 1999 May;106(5):952-7. doi: 10.1016/s0161-6420(99)00515-1.
9
Medical treatment for combined Fusarium and Acanthamoeba keratitis.镰刀菌与棘阿米巴混合性角膜炎的药物治疗
Acta Ophthalmol. 2009 Mar;87(2):199-203. doi: 10.1111/j.1755-3768.2008.01192.x. Epub 2008 May 27.
10
Diagnosis and successful medical treatment of Acanthamoeba keratitis.棘阿米巴角膜炎的诊断与成功的药物治疗
Arch Ophthalmol. 1995 Sep;113(9):1120-3. doi: 10.1001/archopht.1995.01100090046021.

引用本文的文献

1
Keratitis: an update on amebicidal and cysticidal drug screening methodologies and potential treatment with azole drugs.角膜炎:阿米巴和囊虫药物筛选方法的最新进展以及唑类药物的潜在治疗作用。
Expert Rev Anti Infect Ther. 2021 Nov;19(11):1427-1441. doi: 10.1080/14787210.2021.1924673. Epub 2021 May 19.
2
Drug Discovery against Infections: Present Knowledge and Unmet Needs.抗感染药物研发:当前认知与未满足的需求
Pathogens. 2020 May 22;9(5):405. doi: 10.3390/pathogens9050405.
3
The Development of Drugs against Acanthamoeba Infections.
抗棘阿米巴感染药物的研发
Antimicrob Agents Chemother. 2016 Oct 21;60(11):6441-6450. doi: 10.1128/AAC.00686-16. Print 2016 Nov.
4
Screening of the in vitro amoebicidal activities of Pastinaca armenea (Fisch. & C.A.Mey.) and Inula oculus-christi (L.) on Acanthamoeba castellanii cysts and trophozoites.检测防风(Pastinaca armenea(Fisch. & C.A.Mey.))和款冬(Inula oculus-christi(L.))对棘阿米巴包囊和滋养体的体外杀阿米巴活性。
Parasitol Res. 2012 Feb;110(2):565-70. doi: 10.1007/s00436-011-2524-z. Epub 2011 Jul 7.
5
Successful treatment of chronic stromal acanthamoeba keratitis with oral voriconazole monotherapy.口服伏立康唑单药治疗慢性基质棘阿米巴角膜炎获得成功。
Cornea. 2010 Sep;29(9):1066-8. doi: 10.1097/ICO.0b013e3181cbfa2c.
6
In vitro effectiveness of Thymus sipyleus subsp. sipyleus var. sipyleus on Acanthamoeba castellanii and its cytotoxic potential on corneal cells.西皮勒胸腺亚种西皮勒变种对卡氏棘阿米巴的体外有效性及其对角膜细胞的细胞毒性潜力。
Parasitol Res. 2007 Nov;101(6):1551-5. doi: 10.1007/s00436-007-0674-9. Epub 2007 Jul 30.
7
Standardized method of measuring acanthamoeba antibodies in sera from healthy human subjects.测量健康人体血清中棘阿米巴抗体的标准化方法。
Clin Diagn Lab Immunol. 2001 Jul;8(4):724-30. doi: 10.1128/CDLI.8.4.724-730.2001.
8
Free-living, amphizoic and opportunistic amebas.自由生活、兼性寄生和机会性致病的阿米巴。
Brain Pathol. 1997 Jan;7(1):583-98. doi: 10.1111/j.1750-3639.1997.tb01076.x.
9
Amoebicidal efficiencies of various diamidines against two strains of Acanthamoeba polyphaga.各种双脒对两株多食棘阿米巴的杀阿米巴效率。
Antimicrob Agents Chemother. 1995 Feb;39(2):339-42. doi: 10.1128/AAC.39.2.339.
10
Effects of magainins on ameba and cyst stages of Acanthamoeba polyphaga.蛙皮素对多食棘阿米巴滋养体和包囊阶段的影响。
Antimicrob Agents Chemother. 1992 Jun;36(6):1263-71. doi: 10.1128/AAC.36.6.1263.